Tag: MIN

Countries Urged to Establish National Refrigeration Committees to Tackle Food, Health, Animals and Climate Challenges

PARIS, June 26, 2025 /PRNewswire/ -- On the occasion of World Refrigeration Day, the International Institute of Refrigeration (IIR) is calling on all countries to...

Countries Urged to Establish National Refrigeration Committees to Tackle Food, Health, Animals and Climate Challenges

PARIS, June 26, 2025 /PRNewswire/ -- On the occasion of World Refrigeration Day, the International Institute of Refrigeration (IIR) is calling on all countries to...

Countries Urged to Establish National Refrigeration Committees to Tackle Food, Health, Animals and Climate Challenges

PARIS, June 26, 2025 /PRNewswire/ -- On the occasion of World Refrigeration Day, the International Institute of Refrigeration (IIR) is calling on all countries to...

Novo Nordisk A/S: Ozempic® receives EU recommendation in peripheral arterial disease, cementing the broad benefits of semaglutide for people with type 2 diabetes and...

Bagsværd, Denmark, 23 June 2025 – Novo Nordisk today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion for an update of the Ozempic^® (once-weekly semaglutide) label to reflect the positive data from the STRIDE peripheral artery disease (PAD) functional outcomes trial.

Minjee Lee Wins KPMG Women’s PGA Championship With a Callaway Elyte Driver, Callaway Chrome Tour X Golf Ball, and an Odyssey Ai-ONE Square 2...

CARLSBAD, Calif., June 22, 2025 /PRNewswire/ -- Today Callaway Staff Professional Minjee Lee earned her 3rd career major championship at the wind-swept KPMG Women's...

EMA Confluence Validates Trend Continuation Setup

OverviewThe Multiple EMA Trend Confirmation Trading System is rooted in technical analysis, leveraging Exponential Moving Averages (EMAs) and multi-timeframe charts to identify trend direction...

SURGLASSES Launches the World’s First AI Anatomy Table

Asclepius AI Table sets a new benchmark for intelligent, hands-on medical learning. TAIPEI, June 19, 2025 /PRNewswire/ -- Surglasses Inc. today announced the launch of...

Decisions adopted at the Extraordinary General Meeting of Shareholders of LITGRID AB

The following decision was adopted at the Extraordinary General Meeting of Shareholders of LITGRID AB (company code 302564383, registered address at Karlo Gustavo Emilio Manerheimo st. 8, LT-05131, Vilnius) which was held on 19 June 2025:

En termes d’efficacité, une comparaison indirecte des traitements suggère un avantage significatif d’IMBRUVICA® (ibrutinib) associé au vénétoclax par rapport à l’acalabrutinib associé au vénétoclax...

Les résultats d’études croisées de l’association ibrutinib et vénétoclax en première intention montrent un bénéfice clinique significatif pour une durée fixe, ainsi qu’une probabilité accrue de maladie résiduelle minimale indétectable et de survie sans progression par rapport à l’association acalabrutinib et vénétoclax¹

CCTV Focus! Multiple Strategic Agreements Signed! Central New Energy (01735.HK) Makes a Splash at SNEC 2025

SHANGHAI, June 13, 2025 /PRNewswire/ -- SNEC 2025 was grandly held at the National Exhibition and Convention Center (Shanghai) from June 11-13, 2025. Central New...

Significant efficacy benefit of IMBRUVICA® (ibrutinib) plus venetoclax versus acalabrutinib plus venetoclax in frontline treatment of patients with chronic lymphocytic leukaemia suggested by indirect...

Cross-study findings indicate significant clinical benefit of frontline fixed-duration ibrutinib plus venetoclax with improved likelihood of undetectable minimal residual disease and progression-free survival versus acalabrutinib plus venetoclax¹

Energenesis Biomedical to Unveil Promising Parkinson’s Disease Therapy, ENERGI-F705PD, at BIO International 2025

TAIPEI, June 11, 2025 /PRNewswire/ -- Energenesis Biomedical Co., Ltd. (TWSE: 6657), a clinical-stage biotechnology company pioneering cellular energy restoration therapeutics, today announced its...

StarKist® Partners with Feed the Children and Cornerstones for Fourth Annual Summer Food and Resource Rally in Northern Virginia

Hundreds of Families Receive Food and Household Essentials at Resource Rally RESTON, Va., June 6, 2025 /PRNewswire/ -- Hunger remains a significant issue in communities throughout...

NEFECON®: New Results at ERA 2025 Demonstrate Treatment Benefit of the ‘Treat Early’ Strategy

Two new studies on NEFECON® demonstrate its treatment benefit in the "Treat Early" strategy for IgA nephropathy (IgAN), providing robust support for the new disease...

- A word from our sponsors -

Newsletter Signup

Name(Required)

First Last

Email(Required)

Enter Email Confirm Email

CAPTCHA

Privacy(Required)

I agree with the storage and handling of my data by this website. - Privacy Policy *

Comments

This field is for validation purposes and should be left unchanged.

HomeTagsMIN

InterPrivate Investment Partners V, Inc. Announces Closing of $201.25 Million Initial Public Offering

Re: TriWest IV’s Holdings in Source Energy Services Ltd.

Think Together Awards 2026 Beyond Think Together Scholarships to Ten High School Seniors Across the State

Tag: MIN

Countries Urged to Establish National Refrigeration Committees to Tackle Food, Health, Animals and Climate Challenges

Countries Urged to Establish National Refrigeration Committees to Tackle Food, Health, Animals and Climate Challenges

Countries Urged to Establish National Refrigeration Committees to Tackle Food, Health, Animals and Climate Challenges

Novo Nordisk A/S: Ozempic® receives EU recommendation in peripheral arterial disease, cementing the broad benefits of semaglutide for people with type 2 diabetes and...

Minjee Lee Wins KPMG Women’s PGA Championship With a Callaway Elyte Driver, Callaway Chrome Tour X Golf Ball, and an Odyssey Ai-ONE Square 2...

EMA Confluence Validates Trend Continuation Setup

SURGLASSES Launches the World’s First AI Anatomy Table

Decisions adopted at the Extraordinary General Meeting of Shareholders of LITGRID AB

En termes d’efficacité, une comparaison indirecte des traitements suggère un avantage significatif d’IMBRUVICA® (ibrutinib) associé au vénétoclax par rapport à l’acalabrutinib associé au vénétoclax...

CCTV Focus! Multiple Strategic Agreements Signed! Central New Energy (01735.HK) Makes a Splash at SNEC 2025

Significant efficacy benefit of IMBRUVICA® (ibrutinib) plus venetoclax versus acalabrutinib plus venetoclax in frontline treatment of patients with chronic lymphocytic leukaemia suggested by indirect...

Energenesis Biomedical to Unveil Promising Parkinson’s Disease Therapy, ENERGI-F705PD, at BIO International 2025

StarKist® Partners with Feed the Children and Cornerstones for Fourth Annual Summer Food and Resource Rally in Northern Virginia

NEFECON®: New Results at ERA 2025 Demonstrate Treatment Benefit of the ‘Treat Early’ Strategy

Newsletter Signup

Explore

Press Releases

News & Opinion

Living

Others

Follow us